Español
Small interfering RNA molecules (commonly known by the acronym siRNA small interfering RNA) represent one of the most revolutionary innovations in molecular biology and precision medicine. Their discovery, by scientists Andrew Fire and Craig Mello, was a milestone in biological research and was awarded the Nobel Prize in Physiology or Medicine in 2006. History of […]
Category Archives: Noticias
Noticias
BioSpain 2023: record attendance, conferences and with RNA and precision medicine as the protagonist
03
Oct
Oct
Last week, several representatives of the OLIGOFASTX consortium partners attended BioSpain 2023, which has been held from September 26 to 28 at the Fira de Barcelona – Montjuïc, organized by the Spanish Association of Biocompanies (AseBio) in collaboration with Biocat, the Barcelona City Council and the Government of Catalonia. The event has closed a balance […]
International Biotechnology Day 2024, Noticias
European Biotechnology Week: latest developments in the sector
27
Sep
Sep
The European Biotech Week 2023 (European Biotech Week #EBW2023) with various events in the different European countries. The European Biotechnology Week aims to celebrate the biotechnology sector, an innovative and vibrant sector, launched by the discovery of the DNA molecule in 1953.The first European Biotechnology Week in 2013 marked the 60th anniversary of this pivotal […]
15
Sep
Sep
The biotechnology industry continues to grow and evolve, a good proof of this is the large number of professional meetings that take place in these last months of the year. Thanks to these events, scientists and professionals have the opportunity to learn about the latest trends and developments in this field: something essential to promote, […]
30
Aug
Aug
The pharmaceutical industry is a constantly growing sector that plays a fundamental role in the health and well-being of the population The pharmaceutical market has expanded in recent years due to increased demand for health-related products and services; This growth has been largely the result of the quality of employment and the diversity […]
25
Aug
Aug
At OLIGOFASTX we are working to achieve solutions that improve the quality of life of patients affected by rare diseases, and for this we use all the power of technology, knowledge and the expertise from our partners. Like any other public or private entity, all our developments are subject to the different drug authorization processes […]
27
Jul
Jul
In this article, practical advice for parents of children affected by rare diseases will be presented. It will address various situations that may arise in everyday life, with the aim of providing useful tools to deal with them effectively. We hope that this information will be of great help to families in this situation. What […]
Noticias
Innovation on the horizon: how big pharma investment is driving the development of oligonucleotide-based medicines
27
Jun
Jun
The mission of the OLIGOFATSX project is to develop oligonucleotide-based medicines to improve the quality of life of patients affected by rare diseases for which there is still no solution. The scientists involved in the project firmly believe that the future of personalised precision medicine lies in the successful combination of different technologies, including oligonucleotides; […]
15
Jun
Jun
Clear and accessible science communication is essential to bring research advances closer to the general public and to foster understanding and interest in science. In this blog, we will explore the importance of effective communication in science and how it can improve the dissemination of research results. According to a study by Nature, only a […]
24
May
May
The European Week Against Cancer takes place from 25 to 31 May to raise awareness of cancer prevention, access to treatment and support for cancer survivors. From OLIGOFASTX we wanted to offer an overview of the current situation regarding the fight against this disease on the occasion of this week. In recent years, there have […]